| | Identification | Back Directory |  | [Name] 
 Etalocib
 |  | [CAS] 
 161172-51-6
 |  | [Synonyms] 
 VML 295
 Etalocib
 LY293111
 LY293111    Exclusive
 YFIZRWPXUYFCSN-UHFFFAOYSA-N
 Benzoic acid, 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]-
 |  | [Molecular Formula] 
 C33H33FO6
 |  | [MDL Number] 
 MFCD11977723
 |  | [MOL File] 
 161172-51-6.mol
 |  | [Molecular Weight] 
 544.61
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 68-70 °C(Solv: acetonitrile (75-05-8))
 |  | [Boiling point ] 
 656.8±55.0 °C(Predicted)
 |  | [density ] 
 1?+-.0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 Store at -20°C
 |  | [solubility ] 
 DMSO:98.5(Max Conc. mg/mL);173.85(Max Conc. mM)
 |  | [form ] 
 Solid
 |  | [pka] 
 3.32±0.36(Predicted)
 |  | [color ] 
 White to off-white
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 Antineoplastic (inhibits formation of 5-LO, LTB4,LTC4, and thromboxane B2(TxB2); activates PPARγ nuclear receptors).
 |  | [Definition] 
 ChEBI: LY293111 is an aromatic ether.
 |  | [in vivo] 
 
 Etalocib produces a dose-related inhibition of acute leukotriene B4-induced airway obstruction when administered i.v. (ED50=14 μg/kg) or p.o. (ED50=0.4 mg/kg)[2].Etalocib (10 mg/kg) inhibits A23187-induced lung inflammatory changes at 1 h[2].
 Etalocib (250 mg/kg/day, orally) inhibits growth of human pancreatic cancer xenografts in athymic mice[3].
 
 | Animal Model: | Guinea pigs[2]. 
 |  | Dosage: | 1-10 mg/kg. |  | Administration: | Orally once. |  | Result: | A single 1 mg/kg oral dose inhibited excised lung gas volume increases by 76.7±7.1% (n=4, P<0.002) when given 8 h prior to leukotriene B4 challenge, and 28.6±20.3% (n=4, NS) when given 24 h before challenge. Had no effect (10 mg/kg) on pulmonary gas trapping at 1 h or 2 h after A23187 challenge. However, at 4 h, the pulmonary gas trapping response was significantly less than that of vehicle-treated controls and not different from sham values. The 10 mg/kg dose inhibited A23187-induced lung inflammatory changes at 1 h, but was without effect at 2 h or 4 h after challenge.
 
 | 
 |  | [IC 50] 
 LTB4
 | 
 | 
                    
                        
                            | Company Name: | Energy Chemical |  
                            | Tel: | 021-58432009 400-005-6266 |  
                            | Website: | http://www.energy-chemical.com |  |